Annual Cash & Cash Equivalents
$6.61B$492.60M+8.05%
Summary
- Current Value
- As of today, VRTX annual cash & cash equivalents is $6.61B, up +8.05% on
- Historical Performance
- VRTX annual cash & cash equivalents is down -38.71% over the past 3 years, down -0.73% over the past 5 years
- All-Time High Comparison
- VRTX annual cash & cash equivalents is currently -41.09% below its historical high of $11.22B set on
- 3-Year Low Comparison
- VRTX annual cash & cash equivalents is +8.05% above its 3-year low of $6.12B reached on
- Sector Comparison
- VRTX annual cash & cash equivalents is higher than 98.36% of companies in Healthcare sector
Cash and Cash Equivalents Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $6.61B | +8.1% | -38.7% | -0.7% | +541.0% | |
| Quarterly Cash & Cash Equivalents | $7.26B | +16.9% | -30.3% | +4.7% | +781.5% | |
| Price | $442.96 | -1.7% | +33.2% | +109.8% | +733.6% | |
| Annual Current Assets | $11.20B | +16.7% | -15.4% | +37.7% | +959.7% | |
| Annual Total Liabilities | $7.48B | +11.9% | +76.4% | +143.9% | +512.1% | |
| Annual Working Capital | $7.34B | +21.7% | -30.1% | +17.3% | +1160.6% | |
| Annual Net Income | $3.95B | +838.1% | +19.0% | +45.8% | +623.9% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $11.22B | -41.1% | |
| 5Y | $11.22B | -41.1% | |
| All | $11.22B | -41.1% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $6.12B | +8.1% | |
| 5Y | $6.12B | +8.1% | |
| All | $4.40M | >+9999.0% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of VRTX?
As of today, VRTX annual cash & cash equivalents is $6.61B
What is 1-year change in VRTX annual cash & cash equivalents?
VRTX annual cash & cash equivalents is up +8.05% year-over-year
What is 3-year change in VRTX annual cash & cash equivalents?
VRTX annual cash & cash equivalents is down -38.71% over the past 3 years
How far is VRTX annual cash & cash equivalents from its all-time high?
VRTX annual cash & cash equivalents is currently -41.09% below its historical high of $11.22B set on December 31, 2023
How does VRTX annual cash & cash equivalents rank versus sector peers?
VRTX annual cash & cash equivalents is higher than 98.36% of companies in Healthcare sector
When is VRTX next annual earnings release?
As of today, the next annual earnings release for VRTX has not been scheduled
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Quarterly Cash & Cash Equivalents
$7.26B$647.60M+9.80%
Summary
- Current Value
- As of today, VRTX quarterly cash & cash equivalents is $7.26B, up +9.80% on
- Historical Performance
- VRTX quarterly cash & cash equivalents is up +16.85% year-over-year, down -30.34% over the past 3 years
- All-Time High Comparison
- VRTX quarterly cash & cash equivalents is currently -39.18% below its historical high of $11.93B set on
- 3-Year Low Comparison
- VRTX quarterly cash & cash equivalents is +25.25% above its 3-year low of $5.80B reached on
- Sector Comparison
- VRTX quarterly cash & cash equivalents is higher than 98.69% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $7.26B | +9.8% | +16.9% | -30.3% | +4.7% | |
| Annual Cash & Cash Equivalents | $6.61B | – | +8.1% | -38.7% | -0.7% | |
| Price | $442.96 | -3.0% | -1.7% | +33.2% | +109.8% | |
| Quarterly Current Assets | $11.73B | +4.7% | +17.2% | -9.5% | +37.4% | |
| Quarterly Total Liabilities | $7.12B | -4.7% | +11.6% | +56.8% | +127.2% | |
| Quarterly Working Capital | $7.85B | +7.0% | +26.1% | -21.0% | +19.0% | |
| Quarterly Net Income | $1.03B | -13.4% | +59.6% | +47.4% | +57.9% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.26B | at high | |
| 3Y | $11.93B | -39.2% | |
| 5Y | $11.93B | -39.2% | |
| All | $11.93B | -39.2% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.21B | N/A | +16.9% |
| 3Y | $5.80B | +25.3% | |
| 5Y | $5.80B | +25.3% | |
| All | $2.30M | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of VRTX?
As of today, VRTX quarterly cash & cash equivalents is $7.26B
What is VRTX quarterly cash & cash equivalents most recent change?
VRTX quarterly cash & cash equivalents was up +9.80% on March 31, 2026
What is 1-year change in VRTX quarterly cash & cash equivalents?
VRTX quarterly cash & cash equivalents is up +16.85% year-over-year
How far is VRTX quarterly cash & cash equivalents from its all-time high?
VRTX quarterly cash & cash equivalents is currently -39.18% below its historical high of $11.93B set on September 30, 2023
How does VRTX quarterly cash & cash equivalents rank versus sector peers?
VRTX quarterly cash & cash equivalents is higher than 98.69% of companies in Healthcare sector
When is VRTX next earnings release?
The next earnings release for VRTX is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- VRTX Official Website www.vrtx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875320/000087532026000056/0000875320-26-000056-index.htm
- VRTX Profile on Yahoo Finance finance.yahoo.com/quote/VRTX
- VRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrtx